B Thürlimann

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S Michiels, B Asselain, J Bogaerts, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

R. Gelber, A. Goldhirsch, A. Coates, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

M M Regan, S Loibl, M. Gnant, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

B. Thürlimann, H. Senn, R. Lucas, 2006, British Journal of Cancer.